Acute-on-Chronic Liver Failure (ACLF)
What Is Acute-on-Chronic Liver Failure?
Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome characterised by acute deterioration in a patient with chronic liver disease, leading to organ failure(s) and high short-term mortality.
It is not simply “worsening cirrhosis,” but a systemic inflammatory state involving the liver, kidneys, brain, circulation, lungs, and immune system.
ACLF requires urgent recognition and specialised care.
Why ACLF Matters Clinically
ACLF carries a markedly higher short-term mortality compared to stable or decompensated cirrhosis.
The clinical importance lies in:
Rapid progression over days to weeks
Multi-organ involvement
Narrow therapeutic window
Time-sensitive transplant decisions
Delays in recognising ACLF significantly worsen outcomes.
Early vs Advanced ACLF: What Changes?
Early or Low-Grade ACLF
Single organ dysfunction
Potential reversibility with timely intervention
Responsive to infection control and organ support
Transplant may not be immediately required
Advanced or High-Grade ACLF
Multiple organ failures
Severe systemic inflammation
High short-term mortality
Limited reversibility
Urgent transplant consideration or escalation of care
Clinical reality:
ACLF often begins subtly but deteriorates rapidly.
Common Mistakes Patients and Families Make
Assuming sudden deterioration is “expected cirrhosis progression”
Delaying hospitalisation
Underestimating infections without fever
Continuing alcohol or hepatotoxic medications
Seeking multiple opinions instead of coordinated care
Time lost in ACLF cannot be recovered.
When Specialist Input Changes Outcomes
Specialist hepatology input is essential when:
Acute worsening occurs in known liver disease
Kidney function declines rapidly
Mental status changes abruptly
Blood pressure becomes unstable
Infections are suspected or confirmed
Early ICU-level care and transplant centre involvement improve survival.
When Is Liver Transplant Considered in ACLF?
Transplantation is often the only definitive treatment for selected patients with ACLF.
Evaluation depends on:
Number and reversibility of organ failures
Response to initial treatment
Baseline functional status
Timing of deterioration
Key principle:
ACLF is a race against time — both premature and delayed transplant decisions carry risk.
Frequently Asked Questions About ACLF
Is ACLF the same as decompensated cirrhosis?
No. ACLF involves acute systemic inflammation and organ failure.
Can ACLF be reversed?
Early ACLF may improve; advanced ACLF often requires transplantation.
How fast does ACLF progress?
Progression can occur over days.
Is ICU care always required?
Often, especially when organ support is needed.
Does ACLF mean death is inevitable?
No, but prognosis depends on early recognition and management.
Who should manage ACLF?
A multidisciplinary team led by hepatology and transplant specialists.
Clinical Perspective
From a hepatologist’s perspective, ACLF is not a gradual decline — it is a tipping point. Outcomes depend on recognising this transition early and acting decisively within a limited window.